Related Experiment Video
Updated: Jul 18, 2026

Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach
Published on: January 24, 2018
Risk of revision in UKA versus HTO: a nationwide propensity score-matched study
Jae-Doo Yoo1, Min-Hwan Huh1, Young-Soo Shin2
1Department of Orthopedic Surgery, Mokdong Hospital, Ewha Womans University School of Medicine, 1071 Yangchuan Anyangchun-Ro, Seoul, 07985, Republic of Korea.
Introduction:
Our study aims to investigate the incidence rate and risk factors for subsequent revision in patients treated with UKA compared with those treated with HTO.
Methods:
In this retrospective nationwide cohort study, we used data from the Korean National Health Insurance claims database from January 1, 2009 to December 31, 2017. We compared patients who had undergone UKA or HTO as the primary surgical procedure longer than two years prior. We used multivariable logistic regression models to compare risk of revision between the groups after propensity matching with inverse probability of treatment weighting (IPTW). Revision was defined as conversion to total knee arthroplasty (TKA) after primary UKA or HTO.
Results:
In this study, 73,902 patients with UKA and 72,215 patients with HTO were identified after applying IPTW. The risk of revision during the entire study period was higher for patients with HTO than for patients with UKA (adjusted hazard ratio [HR] = 1.42). Kaplan-Meier 8-years survival was 96.8% in the UKA group and 95.1% in the HTO group. Patients with HTO who were at higher risk of revision had advanced age (60-69 years [HR = 2.17, 95% CI 1.76-2.67] and 70-79 years [HR = 2.89, 95% CI 1.81-4.62]), female sex (HR = 1.41, 95% CI 1.19-1.66), CHF (HR = 3.12, 95% CI 1.25-7.78), COPD (HR = 1.68, 95% CI 1.34-2.10), PVD (HR = 1.75, 95% CI 1.10-2.78), and CVA or TIA (HR = 1.87, 95% CI 1.13-3.08) compared with those with UKA.
Conclusion:
Risk of revision was higher for patients with HTO than for patients with UKA. Risk factors for subsequent revision in patients with HTO were advanced age (60-69, 70-79), female sex, and comorbidities such as CHF, COPD, PVD, CVA, or TIA. However, orthopedic surgeons should also consider that TKA conversion from UKA has higher risk of revision than TKA conversion from HTO before choosing between UKA and HTO.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk
Hazard Ratio
For example, in a clinical trial evaluating a...

